Luma Therapeutics has launched a light-based therapy for plaque psoriasis.

The FDA has cleared the Illuvinate™ System, which can be used in a community or home to give relief from psoriasis symptoms. Illuvinate can be prescribed either by a dermatologist or via Luma’s telehealth provider, HealthLens.

Psoriasis is an inflammatory condition resulting in painful, raised patches of skin often found on the scalp, knees, elbows and lower back, and includes depression, cardiovascular disease and Type II diabetes. Previous treatments have included topical steroids, or were available only in a clinical setting.